Education
About Us
Working with TipRanks
Follow Us
Emerging World Pharma (EWPI)
:EWPI
EWPI Stock Chart & Stats
$0.02
$0.00(0.00%)
At close: 4:00 PM EDT
$0.02
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume20.00
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EWPI FAQ
What was Emerging World Pharma’s price range in the past 12 months?
Currently, no data Available
What is Emerging World Pharma’s market cap?
Currently, no data Available
When is Emerging World Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Emerging World Pharma’s earnings last quarter?
Currently, no data Available
Is Emerging World Pharma overvalued?
According to Wall Street analysts Emerging World Pharma’s price is currently Overvalued.
Does Emerging World Pharma pay dividends?
Emerging World Pharma does not currently pay dividends.
What is Emerging World Pharma’s EPS estimate?
Emerging World Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Emerging World Pharma have?
Currently, no data Available
What happened to Emerging World Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Emerging World Pharma?
Currently, no hedge funds are holding shares in EWPI
Company Description
Emerging World Pharma
Emerging World Pharma, Inc. invests in generic based pharmaceutical companies manufacturing within developing nations. It provides production infrastructure, hiring and training of local employees, and raw materials to these companies. The company focuses its investments on pharmaceutical companies that have contracts with church and other non government organizations, government, and wholesalers. Emerging World Pharma, Inc. was formerly known as Tubearoo, Inc. and changed its name to Emerging World Pharma, Inc. in November 2009. The company was founded in 1997 and is based in Sunyani, Ghana.
Technical Analysis
Aptevo Therapeutics
―
Entero Therapeutics
―
Processa Pharmaceuticals
―
NLS Pharmaceutics
―
Bluejay Diagnostics
―